About Craig Asher
Form D filings for Glyphic Biotechnologies in 2024 list Craig Asher as director.
Craig Asher first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Craig Asher in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Craig Asher works with at each company, as listed on that company's latest Form D.
Glyphic Biotechnologies, Inc. · Form D, Feb 16, 2024
JY
Joshua Yang
Chief Executive Officer and director
JY
Jimmy Yun
Director
DE
Daniel Estandian
Executive officer and director